Stegmüller M - Search Results

1

Hormone receptor modulation in xenotransplanted endocrine related human breast cancer.

Michel RT, Vering A, Fortmeyer HP, Stegmüller M. Michel RT, et al. Among authors: stegmuller m. Strahlenther Onkol. 1989 Jul;165(7):497-8. Strahlenther Onkol. 1989. PMID: 2749477 No abstract available.

2

Influence of chemotherapy on hormone receptor concentration in a xenotransplanted endometrial cancer.

Vering A, Michel RT, Mitze M, Stegmüller M, Bender HG. Vering A, et al. Among authors: stegmuller m. Eur J Obstet Gynecol Reprod Biol. 1992 Jul 3;45(2):131-8. doi: 10.1016/0028-2243(92)90229-r. Eur J Obstet Gynecol Reprod Biol. 1992. PMID: 1379946

3

Proliferation characteristics and receptor concentrations in two gynecological carcinomas serially passaged into female nude mice or castrated males.

Vering A, Michel RT, Fortmeyer HP, Stegmüller M. Vering A, et al. Among authors: stegmuller m. Strahlenther Onkol. 1989 Jul;165(7):498-9. Strahlenther Onkol. 1989. PMID: 2749478 No abstract available.

4

[Influences on steroid receptor levels and their significance for clinical practice].

Vering A, Bender HG, Stegmüller M. Vering A, et al. Among authors: stegmuller m. Gynakologe. 1991 Feb;24(1):22-7. Gynakologe. 1991. PMID: 2045003 Review. German. No abstract available.

5

Growth inhibition of xenotransplanted human carcinomas by a monoclonal antibody directed against the epidermal growth factor receptor.

Schnürch HG, Stegmüller M, Vering A, Beckmann MW, Bender HG. Schnürch HG, et al. Among authors: stegmuller m. Eur J Cancer. 1994;30A(4):491-6. doi: 10.1016/0959-8049(94)90425-1. Eur J Cancer. 1994. PMID: 8018408

6

Immuno-biochemical assay for determination of nuclear steroid receptors during tamoxifen therapy.

Vering A, Vockel A, Stegmüller M, Bender HG. Vering A, et al. Among authors: stegmuller m. J Cancer Res Clin Oncol. 1993;119(7):415-20. doi: 10.1007/BF01218423. J Cancer Res Clin Oncol. 1993. PMID: 8491762

7

[Ablativ-hormonal and antihormonal therapeutic trials in a premenopausal breast cancer following heterotransplantation to 200 nu/nu mice].

Michel RT, Bastert G, Fortmeyer HP, Stegmüller M, Kryss J, Schmidt-Matthiesen H. Michel RT, et al. Among authors: stegmuller m. Arch Gynecol. 1979 Jul 20;228(1-4):456. Arch Gynecol. 1979. PMID: 485435 German. No abstract available.

8

[Additive endocrine and antihormonal therapy in postmenopausal breast cancer following heterotransplantation to 300 nu/nu mice].

Michel RT, Bastert G, Fortmeyer HP, Nord D, Stegmüller M, Schmidt-Matthiesen H. Michel RT, et al. Among authors: stegmuller m. Arch Gynecol. 1979 Jul 20;228(1-4):462-3. Arch Gynecol. 1979. PMID: 485443 German. No abstract available.

9

Lymphocyte subsets in patients with ovarian and breast cancer.

Schröder W, Vering A, Stegmüller M, Strohmeier R. Schröder W, et al. Among authors: stegmuller m. Eur J Gynaecol Oncol. 1997;18(6):474-7. Eur J Gynaecol Oncol. 1997. PMID: 9443013

10

Antitumor effect of MAb EMD 55900 depends on EGF-R expression and histopathology.

Solbach C, Sterner-Kock A, Roller M, Schnürch HG, Stegmüller M, Caspar-Bell G, Schumm-Draeger PM, Kaufmann M, Knecht R. Solbach C, et al. Among authors: stegmuller m. Neoplasia. 2002 May-Jun;4(3):237-42. doi: 10.1038/sj.neo.7900236. Neoplasia. 2002. PMID: 11988843 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters